HRID 150598作为反应物
5-fluoro-2-methyl-1-[[4-(methylthio)phenyl]methylene]-1H-indene-3-acetic acid
32004-67-4CSc1ccc(C=C2C(C)=C(CC(=O)O)c3cc(F)ccc32)cc1LFWHFZJPXXOYNR-UHFFFAOYSA-N32004-67-4DTXSID00860606安全信息仅供参考,不能替代供应商安全技术说明书(SDS)、适用法规与专业评估。
Danger
H302 (97.6%): Harmful if swallowed [Warning Acute toxicity, oral]
P203, P233, P260, P261, P264, P270, P271, P272, P280, P284, P301+P317, P302+P352, P304+P340, P318, P321, P330, P333+P317, P342+P316, P362+P364, P403, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 41 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
用途硫化舒林酸是舒林酸的活性代谢产物,舒林酸为前体药物,本身不具有消炎镇痛的活性,而在口服吸收转化为代谢的硫化物而产生作用。用于类风湿性关节炎、臂部和膝关节炎、强直性脊椎炎、滑囊炎、急性痛风等。